Xos (XOS) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The 2025 Annual Meeting will be held virtually on June 24, 2025, with voting on three key proposals: election of two Class I directors, ratification of Grant Thornton LLP as independent auditors, and approval of an amendment to the 2021 Equity Incentive Plan to increase the share reserve by 3.1 million shares.
The board recommends voting in favor of all proposals and emphasizes the importance of shareholder participation via internet, phone, or mail.
Proxy materials are primarily distributed electronically to enhance efficiency and sustainability, with paper copies available upon request.
Voting matters and shareholder proposals
Shareholders will vote on: (1) election of Ed Rapp and Michael Richardson as Class I directors for three-year terms, (2) ratification of Grant Thornton LLP as independent auditors for 2025, and (3) approval of the 2025 Amendment to the 2021 Equity Incentive Plan.
The board has set April 25, 2025, as the record date for voting eligibility.
Shareholder proposals for the 2026 meeting must be submitted by January 10, 2026, for inclusion in the proxy statement.
Board of directors and corporate governance
The board consists of eight members post-meeting, with a majority classified as independent under Nasdaq rules.
Board committees include Audit, Compensation, and Nominating and Corporate Governance, each with defined charters and independent membership.
The board is chaired by the CEO, with a lead independent director to reinforce board independence.
Directors are encouraged to attend the annual meeting, and all but two attended at least 75% of meetings in 2024.
Director compensation includes annual cash retainers and equity awards, with options to receive retainers as RSUs.
Latest events from Xos
- Positive free cash flow, narrowed losses, and growth in powertrains and Hubs set up 2026 expansion.XOS
Q4 202526 Mar 2026 - Q2 2024 revenue up 227% year-over-year, 90 units delivered, but going concern risk remains.XOS
Q2 20241 Feb 2026 - Q3 revenue reached $15.8M with 18.1% gross margin, but liquidity and market risks remain.XOS
Q3 202414 Jan 2026 - Record revenue, positive gross margin, and free cash flow highlight a strong 2024 and outlook.XOS
Q4 202426 Dec 2025 - Key votes include director elections, auditor ratification, and equity plan amendments.XOS
Proxy Filing1 Dec 2025 - Record revenue, deliveries, and free cash flow highlight a milestone quarter despite liquidity risks.XOS
Q2 202523 Nov 2025 - Q3 2025: 130 units, $16.5M revenue, $2.1M net income, but liquidity risks persist.XOS
Q3 202517 Nov 2025 - First positive gross margin achieved, but liquidity risks persist and new capital is needed.XOS
Q1 202517 Nov 2025